FinTechFunding

Actinogen Medical: Files new patent applications

  • Actinogen Medical (ACW) is set to expand its intellectual property portfolio with two new patents
  • The healthcare stock filed the applications for its lead drug candidate, an Alzheimer’s treatment known as Xanamen
  • Positively, the new submissions could extend the drug’s patent life protection up to 2040
  • ACW’s first patent covers a process which seeks to improve cognitive function or treat cognitive decline in healthy adults
  • Meanwhile, the second patent will protect Actinogen’s scale-up manufacturing process
  • Actinogen closed steady following today’s news, with shares worth 2.2 cents each
Previous article
ReadyTech: Completes $25M raise to fund Open Office acquisition
Next article
Mintos: Embarks on crowdfunding camapaing
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Regulators Strengthen Global Crackdown on Finfluencers

A new collaborative approach targets financial influencers amid rising concerns.Highlights: Financial regulators unite to control finfluencers' market impact.Concerns...
FinTech

ECB Strengthens Digital Euro Rollout with Standard Setter Agreements

New collaborations aim to facilitate the digital euro's global integration.Highlights: ECB partners with key global standard setters.Agreements aim...
FinTech

CreditNature Strengthens Nature Restoration Funding Through Everyday Transactions

New partnership enables businesses to support environmental initiatives seamlessly.Highlights: CreditNature teams up with Stabiliti for eco-friendly funding.Businesses can...
FinTech

FedNow Strengthens Instant Payments Security with New API Tool

New API tool enhances security for immediate digital transactions in the U.S.Highlights: FedNow introduces a new API tool...